So far, the effects of JAK–STAT in macrophages, natural killer (NK) cells and T cells on obesity-related inflammation and glucose homeostasis have been studied, and inhibition of the JAK–STAT pathway can partially improve diabetes inflammation and insulin resistance [87–89]. Here, SOAT1 is linked to obesity disorder.